Decoy Receptor 3 Ameliorates an Autoimmune Crescentic Glomerulonephritis Model in Mice
Authors:
- 1 September 2007
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 18 (9) , 2473-2485
Abstract
Autoimmune crescentic glomerulonephritis (ACGN) is a variant of crescentic glomerulonephritis. The outcome of treatment of crescentic glomerulonephritis is poor. Binding of decoy receptor 3 (DCR3) to its ligand is capable of downregulating the alloresponsiveness of T cells. DCR3 has also been shown to benefit an experimental autoimmune model of diabetes. This study tested the hypothesis that a potential immune regulator, DCR3, could prevent the evolution of ACGN. With the use of an established ACGN model in mice, mice were treated with 100 μg/10 g body wt human DCR3 by hydrodynamics-based gene delivery at 14-d intervals. The results showed that the gene therapy resulted in (1) suppression of T and B cell activation and T cell proliferation; (2) a reduction in serum levels of proinflammatory cytokines; (3) improvement of proteinuria and renal dysfunction; (4) prevention of glomerular crescent formation, renal interstitial inflammation, and glomerulosclerosis; (5) a reduction in serum levels of autoantibodies and glomerular immune deposits; (6) inhibition of apoptosis in the spleen and kidney; (7) prevention of T cell and macrophage infiltration of the kidney; and (8) suppression of fibrosis-related gene expression in the kidney compared with empty vector–treated (disease control) ACGN mice. On the basis of these findings, it is proposed that human DCR3 exerts its preventive and protective effects on ACGN through modulation of T cell activation/proliferation, B cell activation, protection against apoptosis, and suppression of mononuclear leukocyte infiltration in the kidney.Keywords
This publication has 41 references indexed in Scilit:
- Glomerular crescent-related biomarkers in a murine model of chronic graft versus host diseaseNephrology Dialysis Transplantation, 2005
- T- and B-Cell Abnormalities in Systemic Lupus ErythematosusCritical Reviews in Immunology, 2005
- Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY ratsNephrology Dialysis Transplantation, 2004
- T cells in the pathogenesis of systemic lupus erythematosusClinical Immunology, 2004
- Systemic Lupus Erythematosus and Apoptosis: A Question of BalanceClinical Reviews in Allergy & Immunology, 2003
- Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancerNature, 1998
- Haemophilus influenzae and Streptococcus pneumoniae induce different intracerebral mRNA cytokine patterns during the course of experimental bacterial meningitisClinical and Experimental Immunology, 1997
- Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus.Journal of Clinical Investigation, 1995
- Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen.Journal of Clinical Investigation, 1993
- A systemic lupus erythematosus (SLE)‐like disease in mice induced by abnormal T‐B cell cooperation. Preferential formation of autoantibodies characteristic of SLEEuropean Journal of Immunology, 1982